Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients.
about
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohortAuditory Alterations in Children Infected by Human Immunodeficiency Virus Verified Through Auditory Processing TestAssessment of nutrient supplement to reduce gentamicin-induced ototoxicity.Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.The need to accelerate access to new drugs for multidrug-resistant tuberculosis.d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models.Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant TuberculosisThe medical and surgical treatment of drug-resistant tuberculosis.In vitro assessment of antiretroviral drugs demonstrates potential for ototoxicity.An audiological profile of patients infected with multi-drug resistant tuberculosis at a district hospital in KwaZulu-Natal.The prevalence of hearing impairment within the Cape Town Metropolitan area.Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis.Public awareness of audiology, hearing and hearing health in the Limpopo Province, South Africa.Monitoring neonates for ototoxicity.Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection.
P2860
Q27318102-5FDDD9EE-E12C-4B7D-A595-B84DEF6B01FBQ30366324-63520E22-EF2F-42B9-8297-0E5D312430B5Q30410332-76512FB5-6F58-40C3-8C30-48200D372224Q34874579-E390EE63-2F10-4F56-AB97-C53206A96C9DQ35815071-B895B9E1-0ADD-4D6C-8B43-DC8A0D58DCFFQ36446781-BE3C2F47-284A-42AC-8AAE-AC5C62EE3558Q37060143-859FBF5B-920C-4383-9E78-25B10F625D00Q37629518-BB731C85-D04B-4B68-BDD3-233F737D01DFQ38700376-07D550BA-D4F7-4DF2-8871-D7D09F6F4553Q38982543-796DCA85-E0E4-4ACC-8396-E71F6192D4C3Q39720050-15AF6E07-3CA3-48BC-AA09-DB9B57AC751AQ40139987-5FA27AE5-AC86-4E01-840D-136F96C4482DQ46976782-1A2710A0-796A-4118-B518-02BCD88D37ADQ48287747-FCA1F793-1B19-4CBE-A168-01D53D52E8B6Q55407610-8C7F95BF-E09C-4A36-A61A-1BD8DB102E4B
P2860
Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Aminoglycoside-induced hearing ...... sistant tuberculosis patients.
@en
Aminoglycoside-induced hearing ...... sistant tuberculosis patients.
@nl
type
label
Aminoglycoside-induced hearing ...... sistant tuberculosis patients.
@en
Aminoglycoside-induced hearing ...... sistant tuberculosis patients.
@nl
prefLabel
Aminoglycoside-induced hearing ...... sistant tuberculosis patients.
@en
Aminoglycoside-induced hearing ...... sistant tuberculosis patients.
@nl
P2093
P356
P1476
Aminoglycoside-induced hearing ...... esistant tuberculosis patients
@en
P2093
Greetje De Jong
H Simon Schaaf
Johannes J Fagan
Lucretia Petersen
Soraya Bardien
Tashneem Harris
P304
P356
10.7196/SAMJ.4964
P433
P577
2012-05-08T00:00:00Z